SINTHealthcare · Medical DevicesThe 4 Wall Street analysts covering SINTX Technologies, Inc. hold a median 12-month price target of $9.25 — +338.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 28 of 100 as at 8 Oct 2026 — in the lower half. The Street sees upside; the factor read is a caution. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores SINTX Technologies, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (90): Smaller than most of the companies we track.
Value (6): The shares cost a lot relative to the profits and assets behind them.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on SINT, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +338.4% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 1 Oct 2026 | Ascendiant Capital | Maintains | Buy | $12 → $13 |
| 4 June 2026 | Maxim Group | Reinstates | Buy | $6.00 |
| 20 May 2026 | HC Wainwright & Co. | Reiterates | Buy | — |
| 13 Apr 2026 | HC Wainwright & Co. | Initiates | Buy | — |
| 8 Apr 2026 | Ascendiant Capital | Maintains | Buy | — |
| 8 Dec 2025 | Ascendiant Capital | Maintains | Buy | — |
| 22 Sept 2025 | Ascendiant Capital | Maintains | Buy | — |
| 30 May 2025 | Ascendiant Capital | Maintains | Buy | — |
| 21 Apr 2025 | Ascendiant Capital | Maintains | Buy | — |
| 5 Feb 2024 | Maxim Group | Downgrade | Hold | — |
| 3 Apr 2023 | Maxim Group | Maintains | Buy | — |
| 15 Feb 2023 | Maxim Group | Maintains | Buy | — |
| 20 Jan 2023 | Maxim Group | Maintains | Buy | — |
| 3 Aug 2020 | Maxim Group | Upgrade | Buy | $4.50 |
| 12 Sept 2019 | Ascendiant Capital | Initiates | Buy | — |
| 11 Sept 2019 | Ascendiant Capital | Initiates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. SINT appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 8 Oct 2026, SINTX Technologies, Inc. returned −53.3% against +16.2% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 80% of US stocks
Cheaper than 13% of US stocks
Cheaper than 32% of US stocks
Cheaper than 69% of US stocks
Higher than 96% of US stocks
Higher than 93% of US stocks
Higher than 74% of US stocks
Higher than 7% of US stocks
Higher than 85% of US stocks
Higher than 6% of US stocks
Higher than 5% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
SINTX Technologies, Inc. has a market value of $14.5M and an enterprise value of $14.1M.
Revenue in the twelve months to 30 June 2026: $1.1M. The latest quarter grew 199.3% year on year.
Net income over the same four quarters: −$11.3M, a −1039.7% net margin.
Free cash flow in the twelve months to 30 June 2026: −$10.3M.
SINTX Technologies, Inc. spent $0.0 on share buybacks in the twelve months to 30 June 2026.
Trailing P/E: −0.4×; forward P/E: −2.0× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
SINTX Technologies, Inc. employs 32 people — $34K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own SINTX Technologies, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
SINTX Technologies was upgraded to Zacks Rank #2 (Buy), reflecting growing optimism about its earnings prospects. The source says this might drive the stock higher in the near term.
Why it matters — The upgrade signals increased optimism about SINTX's earnings prospects.
SINTX announced preliminary, unaudited third-quarter revenue of $2.2 million, exceeding the high end of its prior guidance of $0.9–1.1 million and representing roughly 380% growth from Q2, driven by stronger-than-expected industrial ceramics sales to Fortune 500 customers. The milestone also enabled the company to call its Class B warrants, and it reiterated its Q4 revenue guidance.
Why it matters — Revenue coming in well above guidance signals improving industrial demand and broader operational progress for SINTX, a key metric for watchers tracking the company's performance.
SINTX Technologies announced the availability of a Company-sponsored Masterclass hosted by Orthopedics This Week, featuring three industry experts in implant retrieval, biomaterials, and clinical practice. The session examines the science, clinical experience, and potential advantages of silicon nitride relative to established implant materials for orthopedic applications.
Why it matters — A SINT watcher would care because the Masterclass raises awareness of silicon nitride's potential value among a leading orthopedic industry publication audience, supporting visibility of SINTX's core technology platform.
SINTX Technologies announced it will participate in the 28th Annual H.C. Wainwright Global Investment Conference. The company, which commercializes silicon nitride technologies for medical and other high-value applications, made the announcement on September 8, 2026.
Why it matters — Participation in a major investment conference gives SINTX a platform to present its business to potential investors and industry participants.
SINTX Technologies was upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. The upgrade could potentially drive the stock higher in the near term.
Why it matters — A Zacks upgrade signals improving analyst sentiment toward SINTX's earnings outlook, which SINT watchers would view as a positive development.
The 4 Wall Street analysts covering SINTX Technologies, Inc. have a median 12-month price target of $9.25, with estimates ranging from $6 to $13. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 4 analysts covering SINTX Technologies, Inc., 4 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks SINTX Technologies, Inc. 28 out of 100 across roughly 4,600 US stocks as at 8 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 8 Oct 2026, SINTX Technologies, Inc. ranks 28 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (90 of 100).
No one can know that. What the data says: the median 12-month target from 4 analysts implies +338.4% from the last close, and Ticker Nerd's factor model ranks SINTX Technologies, Inc. 28 out of 100 as at 8 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering SINTX Technologies, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SINT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $6 to $13 over the next 12 months.
SINTX Technologies, Inc. returned -53.3% over the 12 months to 8 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
SINTX Technologies, Inc. Common Stock represents SINTX Technologies, Inc., an advanced ceramics company focused on silicon nitride–based materials and medical technologies.
The most recent item we track (Zacks Investment Research, 8 Oct 2026): "What Makes SINTX TECHNOLOGIES (SINT) a New Buy Stock". SINTX Technologies was upgraded to Zacks Rank #2 (Buy), reflecting growing optimism about its earnings prospects. The source says this might drive the stock higher in the near term.
SINTX Technologies, Inc. Common Stock represents SINTX Technologies, Inc., an advanced ceramics company focused on silicon nitride–based materials and medical technologies. SINTX develops, manufactures, and commercializes biomaterials, components, and related products for biomedical, technical, and antipathogenic applications. Its portfolio includes solid and porous silicon nitride materials, silicon nitride powders and coatings, composite materials, and finished medical device products used in areas such as spinal, foot and ankle, dental, and joint reconstruction. The company also supports contract manufacturing and other advanced ceramics opportunities, using its materials science platform for both medical and high-value industrial applications. Headquartered in Salt Lake City, Utah, SINTX plays a specialized role in the healthcare materials market by supplying high-performance ceramic solutions designed for durability, biocompatibility, and antimicrobial properties.
CEO Mr. Eric K. Olson · 32 employees · United States · https://www.sintx.com
